464 related articles for article (PubMed ID: 26997445)
1. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
[TBL] [Abstract][Full Text] [Related]
2. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.
Lawrie CH; Chi J; Taylor S; Tramonti D; Ballabio E; Palazzo S; Saunders NJ; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS
J Cell Mol Med; 2009 Jul; 13(7):1248-60. PubMed ID: 19413891
[TBL] [Abstract][Full Text] [Related]
3. MiR-7e-5p downregulation promotes transformation of low-grade follicular lymphoma to aggressive lymphoma by modulating an immunosuppressive stroma through the upregulation of FasL in M1 macrophages.
Lou X; Fu J; Zhao X; Zhuansun X; Rong C; Sun M; Niu H; Wu L; Zhang Y; An L; Guo L; Wan S; Wang S
J Exp Clin Cancer Res; 2020 Nov; 39(1):237. PubMed ID: 33168041
[TBL] [Abstract][Full Text] [Related]
4.
Musilova K; Devan J; Cerna K; Seda V; Pavlasova G; Sharma S; Oppelt J; Pytlik R; Prochazka V; Prouzova Z; Trbusek M; Zlamalikova L; Liskova K; Kruzova L; Jarosova M; Mareckova A; Kornauth C; Simonitsch-Klupp I; Schiefer AI; Merkel O; Mocikova H; Burda P; Machova Polakova K; Kren L; Mayer J; Zent CS; Trneny M; Evans AG; Janikova A; Mraz M
Blood; 2018 Nov; 132(22):2389-2400. PubMed ID: 30213873
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
6. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.
Wu PY; Zhang XD; Zhu J; Guo XY; Wang JF
Hum Pathol; 2014 Aug; 45(8):1664-73. PubMed ID: 24931464
[TBL] [Abstract][Full Text] [Related]
7. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
Meng Y; Quan L; Liu A
Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
[TBL] [Abstract][Full Text] [Related]
8. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions.
Lossos IS; Levy R
Semin Cancer Biol; 2003 Jun; 13(3):191-202. PubMed ID: 12959350
[TBL] [Abstract][Full Text] [Related]
9. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.
Lossos IS; Alizadeh AA; Diehn M; Warnke R; Thorstenson Y; Oefner PJ; Brown PO; Botstein D; Levy R
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8886-91. PubMed ID: 12077300
[TBL] [Abstract][Full Text] [Related]
10. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment].
Cao QW; Li HY; Yao XX; Wang JF
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792
[TBL] [Abstract][Full Text] [Related]
11. Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma.
Berglund M; Enblad G; Thunberg U; Amini RM; Sundström C; Roos G; Erlanson M; Rosenquist R; Larsson C; Lagercrantz S
Mod Pathol; 2007 Jan; 20(1):63-75. PubMed ID: 17170743
[TBL] [Abstract][Full Text] [Related]
12. Histological progression of follicular lymphoma associated with p53 mutation and rearrangement of the C-MYC gene.
Takimoto Y; Takafuta T; Imanaka F; Kuramoto A; Sasaki N; Nanba K
Hiroshima J Med Sci; 1996 Jun; 45(2):69-73. PubMed ID: 8810134
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma.
Arzuaga-Mendez J; Lopez-Santillan M; Garcia-Ruiz JC; Lopez-Lopez E; Martin-Guerrero I
Crit Rev Oncol Hematol; 2021 Mar; 159():103247. PubMed ID: 33515703
[TBL] [Abstract][Full Text] [Related]
14. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
[TBL] [Abstract][Full Text] [Related]
15. BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5' regulatory region of the BCL-6 gene.
Lossos IS; Warnke R; Levy R
Leukemia; 2002 Sep; 16(9):1857-62. PubMed ID: 12200704
[TBL] [Abstract][Full Text] [Related]
16. Angiomirs expression profiling in diffuse large B-Cell lymphoma.
Borges NM; do Vale Elias M; Fook-Alves VL; Andrade TA; de Conti ML; Macedo MP; Begnami MD; Campos AH; Etto LY; Bortoluzzo AB; Alves AC; Young KH; Colleoni GW
Oncotarget; 2016 Jan; 7(4):4806-16. PubMed ID: 26683099
[TBL] [Abstract][Full Text] [Related]
17. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.
Fan Q; Meng X; Liang H; Zhang H; Liu X; Li L; Li W; Sun W; Zhang H; Zen K; Zhang CY; Zhou Z; Chen X; Ba Y
Protein Cell; 2016 Dec; 7(12):899-912. PubMed ID: 27815824
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.
Hother C; Rasmussen PK; Joshi T; Reker D; Ralfkiær U; Workman CT; Heegaard S; Ralfkiær E; Grønbæk K
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5169-75. PubMed ID: 23821202
[TBL] [Abstract][Full Text] [Related]
19. MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1).
Wang Y; Guo D; Li B; Wang Y; Wang B; Wang Z; Wang M; Teng Q
Leuk Res; 2022 Jan; 112():106769. PubMed ID: 34875555
[TBL] [Abstract][Full Text] [Related]
20. Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
Andréasson U; Dictor M; Jerkeman M; Berglund M; Sundström C; Linderoth J; Rosenquist R; Borrebaeck CA; Ek S
Am J Hematol; 2009 Dec; 84(12):803-8. PubMed ID: 19844990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
